These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22441791)

  • 21. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Naratriptan hydrochloride in extemporaneosly compounded oral suspensions.
    Zhang YP; Trissel LA; Fox JL
    Int J Pharm Compd; 2000; 4(1):69-71. PubMed ID: 23985892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of extemporaneous erlotinib, lapatinib, and imatinib oral suspensions.
    Li Q; Liu Z; Kolli S; Wetz K; Griffith N; Poi MJ
    Am J Health Syst Pharm; 2016 Sep; 73(17):1331-7. PubMed ID: 27543577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stability of propylthiouracil in extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Trowbridge JM
    Am J Health Syst Pharm; 2000 Jun; 57(12):1141-3. PubMed ID: 10911513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of lamotrigine in two extemporaneously prepared oral suspensions at 4 and 25 degrees C.
    Nahata MC; Morosco RS; Hipple TF
    Am J Health Syst Pharm; 1999 Feb; 56(3):240-2. PubMed ID: 10030509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions.
    Kabiche D; Balde IB; Majoul E; Kabiche S; Bourguignon E; Fontan JE; Cisternino S; Schlatter J
    Int J Pharm Compd; 2017; 21(2):160-163. PubMed ID: 28346212
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stability of pentoxifylline in an extemporaneously prepared oral suspension.
    Abdel-Rahman S; Nahata MC
    Am J Health Syst Pharm; 1997 Jun; 54(11):1301-3. PubMed ID: 9179352
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temozolomide stability in extemporaneously compounded oral suspensions.
    Trissel LA; Zhang Y; Koontz SE
    Int J Pharm Compd; 2006; 10(5):396-9. PubMed ID: 23974320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of ganciclovir in extemporaneously compounded oral liquids.
    Anaizi NH; Swenson CF; Dentinger PJ
    Am J Health Syst Pharm; 1999 Sep; 56(17):1738-41. PubMed ID: 10512505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of itraconazole in an extemporaneously compounded oral liquid.
    Jacobson PA; Johnson CE; Walters JR
    Am J Health Syst Pharm; 1995 Jan; 52(2):189-91. PubMed ID: 12879547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stability of valacyclovir hydrochloride in extemporaneously prepared oral liquids.
    Fish DN; Vidaurri VA; Deeter RG
    Am J Health Syst Pharm; 1999 Oct; 56(19):1957-60. PubMed ID: 10554914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extemporaneous sildenafil citrate oral suspensions for the treatment of pulmonary hypertension in children.
    Nahata MC; Morosco RS; Brady MT
    Am J Health Syst Pharm; 2006 Feb; 63(3):254-7. PubMed ID: 16434784
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of ursodiol 25 mg/mL in an extemporaneously prepared oral liquid.
    Mallett MS; Hagan RL; Peters DA
    Am J Health Syst Pharm; 1997 Jun; 54(12):1401-4. PubMed ID: 9194984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of an extemporaneously compounded clonidine hydrochloride oral liquid.
    Levinson ML; Johnson CE
    Am J Hosp Pharm; 1992 Jan; 49(1):122-5. PubMed ID: 1570852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stability of zonisamide in extemporaneously compounded oral suspensions.
    Abobo CV; Wei B; Liang D
    Am J Health Syst Pharm; 2009 Jun; 66(12):1105-9. PubMed ID: 19498126
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical stability of extemporaneously prepared Lorazepam suspension at two temperatures.
    Lee WM; Lugo RA; Rusho WJ; Mackay M; Sweeley J
    J Pediatr Pharmacol Ther; 2004 Oct; 9(4):254-8. PubMed ID: 23118704
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stability of extemporaneously prepared acetylcysteine 1% and 10% solutions for treatment of meconium ileus.
    Fohl AL; Johnson CE; Cober MP
    Am J Health Syst Pharm; 2011 Jan; 68(1):69-72. PubMed ID: 21164069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stability of sunitinib in oral suspension.
    Navid F; Christensen R; Minkin P; Stewart CF; Furman WL; Baker S
    Ann Pharmacother; 2008 Jul; 42(7):962-6. PubMed ID: 18577759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of a pyrimethamine suspension compounded from bulk powder.
    Lewis PO; Cluck DB; Huffman JD; Ogle AP; Brown SD
    Am J Health Syst Pharm; 2017 Dec; 74(24):2060-2064. PubMed ID: 29222363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.